TY  - JOUR
AU  - Jimenez-Lucena, Rosa
AU  - Rangel-Zuñiga, Oriol Alberto
AU  - Alcala-Diaz, Juan Francisco
AU  - Lopez-Moreno, Javier
AU  - Roncero-Ramos, Irene
AU  - Molina-Abril, Helena
AU  - Yubero-Serrano, Elena Maria
AU  - Caballero-Villarraso, Javier
AU  - Delgado-Lista, Javier
AU  - Castaño, Justo Pastor
AU  - Ordovas, Jose Maria
AU  - Perez-Martinez, Pablo
AU  - Camargo, Antonio
AU  - Lopez-Miranda, Jose
PY  - 2018
DO  - 10.1016/j.omtn.2018.05.002
SN  - 2162-2531
UR  - http://hdl.handle.net/10668/12923
T2  - Molecular Therapy. Nucleic acids
AB  - Circulating microRNAs (miRNAs) have been proposed as type 2 diabetes biomarkers, and they may be a more sensitive way to predict development of the disease than the currently used tools. Our aim was to identify whether circulating miRNAs, added to...
LA  - en
PB  - Cell Press
KW  - Biomarkers
KW  - miRNAs
KW  - Predictive models
KW  - Type 2 diabetes mellitus
KW  - Humans
KW  - Glycated Hemoglobin
KW  - Diabetes Mellitus, Type 2
KW  - Follow-Up Studies
KW  - Area Under Curve
KW  - ROC Curve
KW  - MicroRNAs
KW  - Biomarkers
KW  - Early Diagnosis
KW  - Regression Analysis
KW  - Polymerase Chain Reaction
TI  - Circulating miRNAs as Predictive Biomarkers of Type 2 Diabetes Mellitus Development in Coronary Heart Disease Patients from the CORDIOPREV Study.
TY  - research article
VL  - 12
ER  -